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ysosome-related organelles are cell type–speciﬁc intra-
cellular compartments with distinct morphologies and
functions. The molecular mechanisms governing the
formation of their unique structural features are not known.
Melanosomes and their precursors are lysosome-related
 
organelles that are characterized morphologically by
intralumenal ﬁbrous striations upon which melanins are
polymerized. The integral membrane protein Pmel17 is a
component of the ﬁbrils and can nucleate their formation
in the absence of other pigment cell–speciﬁc proteins.
Here, we show that formation of intralumenal ﬁbrils requires
L
 
cleavage of Pmel17 by a furin-like proprotein convertase
(PC). As in the generation of amyloid, proper cleavage of
Pmel17 liberates a lumenal domain fragment that becomes
incorporated into the ﬁbrils; longer Pmel17 fragments
generated in the absence of PC activity are unable to form
organized ﬁbrils. Our results demonstrate that PC-dependent
cleavage regulates melanosome biogenesis by controlling the
ﬁbrillogenic activity of a resident protein. Like the pathologic
process of amyloidogenesis, the formation of other tissue-
speciﬁc organelle structures may be similarly dependent on
proteolytic activation of physiological ﬁbrillogenic substrates.
 
Introduction
 
Organelle function and morphology are intimately related,
yet the molecular mechanisms that underlie organelle mor-
phogenesis are largely uncharacterized. Organelle morphol-
ogy within the central vacuolar system is controlled by ex-
trinsic factors, such as cytoskeletal or “matrix” proteins (De
Matteis and Morrow, 2000; Warren and Shorter, 2002),
and by intrinsic factors, such as resident integral membrane
and lumenal contents (Valladeau et al., 2000). Organelle
morphogenesis must be regulated to ensure proper temporal
and spatial control; disregulation may result in disease, as ex-
emplified by the defects in lysosome-related organelles in pa-
tients with Hermansky-Pudlak Syndrome and correspond-
ing mouse models (Swank et al., 1998; Spritz, 1999;
Dell’Angelica et al., 2000). Understanding how morphogen-
esis of lysosome-related organelles is controlled may help to
elucidate the etiology of these disorders.
Melanosomes serve as an excellent model to define bioge-
netic mechanisms among lysosome-related organelles. Me-
lanosomes are specialized organelles within melanocytes and
retinal pigment epithelial cells in which melanin pigments
are generated and stored (Marks and Seabra, 2001; Raposo
and Marks, 2002). As they are synthesized within maturing
(stage III and IV) melanosomes, melanins are deposited
along characteristic intralumenal fibers that appear before
pigment deposition in stage II premelanosomes. Like the
dense cores of secretory granules, the fibers serve to sequester
and concentrate cargo—in this case melanins; they also
likely function to detoxify oxidative melanin intermediates
(Seiji et al., 1963; King et al., 1995). The fibers are thought
to be proteinaceous because they lack the ultrastructural
hallmarks of a lipid bilayer (Moyer, 1966; Maul, 1969;
Hearing et al., 1973). Thus, they are similar to intralumenal
fibrils that form in certain pathologies associated with amy-
loid deposition (Badman et al., 1996; Kim et al., 1999;
Chen et al., 2001). The formation of fibrils represents a key
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step in melanosome biogenesis, but their composition and
the molecular mechanisms underlying their formation are
unknown.
Pmel17 (also known as gp100, ME20, and Silver) is a
type I integral membrane protein, uniquely expressed by
melanocytes and retinal pigment epithelial cells, that local-
izes to the premelanosome matrix (Kwon et al., 1987; Ven-
negoor et al., 1988; Adema et al., 1994; Kobayashi et al.,
1994; Zhou et al., 1994; Lee et al., 1996; Raposo et al.,
2001). A role for Pmel17 in melanosome function is sup-
ported by the pigmentation defect in 
 
silver
 
 mice (Dunn and
Thigpen, 1930), in which the Pmel17 protein is truncated
(Martínez-Esparza et al., 1999). Pmel17 immunolocalizes to
the fibrils within stage II premelanosomes (Berson et al.,
2001; Raposo et al., 2001), and Pmel17 expression is suffi-
cient to induce the formation of premelanosome-like fibrils
within multivesicular bodies (MVBs)* of nonpigment cells
(Berson et al., 2001). Nevertheless, Pmel17 in nondenatur-
ing detergent extracts of melanocytes or transfected HeLa
cells remains covalently tethered to its transmembrane do-
main, even after the precursor polypeptide is cleaved into
two fragments (Berson et al., 2001). This implies a contin-
ued association with membranes, belying the inferred non-
membranous nature of the striations. To probe the mecha-
nism by which Pmel17 initiates fibril formation, we asked
(1) what is the function of the intralumenal cleavage; and (2)
what is the biochemical nature of Pmel17 on the intralume-
nal striations? Our results highlight a role for proprotein
convertases (PCs) in organelle biogenesis, and reveal a strik-
ing parallel between the formation of the morphological
hallmark of premelanosomes and the pathological fibril for-
mation in amyloid disease.
 
Results
 
Identification of Pmel17 cleavage site and proteolysis 
by a PC
 
In human melanocytes, melanoma cells, and transfected
nonpigment cells, Pmel17 is proteolytically cleaved within a
post-Golgi compartment (Berson et al., 2001). Intralumenal
cleavage generates a COOH-terminal 28-kD M
 
 
 
 fragment
containing part of the lumenal domain and the entire trans-
membrane and cytoplasmic domains, and an 
 
 
 
80-kD M
 
 
 
fragment consisting of the remaining NH
 
2
 
-terminal region
of the lumenal domain (Fig. 1 A). Both fragments are stoi-
chiometrically coprecipitated from cell lysates prepared
with Triton X-100 (TX); a small amount of M
 
 
 
, free of
M
 
 
 
, is precipitated from cell supernatants (Berson et al.,
2001). M
 
 
 
 migrates identically to ME-20s, consisting of
 
Figure 1.
 
Identification of a conserved PC cleavage site in Pmel17.
 
 
(A) Schematic diagram of the primary structure of Pmel17 drawn to 
scale. Numbers correspond to amino acid positions; positions of the 
signal sequence (SS), transmembrane (TM), and cytoplasmic (Cyt.) 
domains, aa 469, and a lumenal region deleted in the alternative 
spliced form, Pmel17-s, are indicated; N-linked glycans are 
represented by branched structures; regions corresponding to M
 
 
 
 
and M
 
 
 
 are shown above; and regions recognized by antibodies 
 
 
 
Pmel-N, HMB50, and 
 
 
 
Pep13h are shown below. (B) Sequence 
of the conserved dibasic consensus site from orthologues human 
Pmel17 (GenBank/EMBL/DDBJ accession no. NP_008859), chicken 
MMP115 (GenBank/EMBL/DDBJ accession no. Q98917), bovine 
RPE1 (GenBank/EMBL/DDBJ accession no. Q06154), equine Pmel17 
(GenBank/EMBL/DDBJ accession no. AAC97108), and mouse Silver 
(GenBank/EMBL/DDBJ accession no. NP_068682). Amino acid 
positions are noted (equine and bovine sequences are from incomplete 
clones); conserved residues are in gray. Top, Pmel17
 
 
 
cs (
 
 
 
cs) 
sequence. Right, consensus recognition sequence for furin; cleavage 
site is indicated by arrow. (C) Cleavage is inhibited by mutagenesis of 
the dibasic site. Transiently transfected HeLa cells expressing wild-
type Pmel17 (WT) or Pmel17
 
 
 
cs (
 
 
 
cs) were metabolically pulse 
labeled and chased as indicated. TX cell lysates at each time point 
were immunoprecipitated with 
 
 
 
PEP13h, fractionated by SDS-PAGE, 
and analyzed by phosphorimaging. Shown are regions of the gels 
encompassing the relevant bands; the signal from the lower region 
was enhanced fourfold to emphasize the failure to detect M
 
 
 
 from 
Pmel17
 
 
 
cs. Migration of molecular weight markers and P1, P2, M
 
 
 
, 
and M
 
 
 
 forms of Pmel17 are indicated. (D and E) Western blot 
analysis of wild-type Pmel17 (WT) and Pmel17
 
 
 
cs (
 
 
 
cs) expressed 
transiently by transfection in (D) HeLa or (E) LoVo cells. In E, LoVo 
cells were cotransfected (
 
 
 
) or not (
 
 
 
) with a plasmid encoding rat 
furin. Whole-cell lysates from transfected cells were fractionated 
by SDS-PAGE, transferred to PVDF membranes, and probed using 
 
 
 
PEP13h with enhanced chemifluorescence. Positions of molecular 
weight markers and P1 and M
 
  
 
forms of
 
 
 
Pmel17 are indicated.T
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Pmel17 residues 25–467, identified in melanoma cell super-
natants (Maresh et al., 1994).
Immediately after V
 
467
 
 in Pmel17 is a conserved dibasic
pair within a consensus sequence that is similar to the recog-
nition element for PCs of the furin family of proteases (Fig.
1 B; Hosaka et al., 1991). PCs and associated carboxypepti-
dases mediate regulated cleavage of proproteins within late
secretory compartments and endosomes (Steiner, 1998;
Varlamov and Fricker, 1998; Thomas, 2002). ME20s/M
 
 
 
could potentially be generated by PC-dependent cleav-
age at R
 
469
 
 followed by removal of the dibasic pair by a
carboxypeptidase D- or E-like activity. To determine
whether Pmel17 cleavage requires the dibasic pair, KR
 
468–469
 
was altered to QQ by site-directed mutagenesis, generat-
ing Pmel17
 
 
 
cs (Fig. 1 B). Unlike wild-type Pmel17,
Pmel17
 
 
 
cs expressed in transfected HeLa cells was not pro-
cessed to M
 
 
 
 and M
 
 
 
 (Fig. 1, C and D). Instead, cells accu-
mulated the P2 form, representing full-length Pmel17
 
 
 
cs
with Golgi-modified N-linked glycans (Berson et al., 2001).
Furthermore, although cells expressing wild-type Pmel17 se-
crete low levels of M
 
 
 
 into the medium, cells expressing
Pmel17
 
 
 
cs did not (unpublished data).
To determine whether PCs are required for the cleavage,
Pmel17 or the 
 
 
 
cs variant were expressed in LoVo, a human
adenocarcinoma cell line lacking furin (Takahashi et al.,
1995) and several other PCs (Miranda et al., 1996). Cleav-
age in transfected LoVo or control HeLa cells was assessed
by Western blotting of whole-cell lysates with 
 
 
 
PEP13h, an
antibody to the cytoplasmic domain. Lysates from HeLa
cells expressing wild-type Pmel17, like melanocytic cells,
contain two immunoreactive bands with M
 
r
 
 28,000 and
 
 
 
100,000, representing M
 
 
 
 and the full-length, endogly-
cosidase H (endoH)-sensitive P1 precursor, respectively
(Fig. 1 D; see Fig. 5 A). By contrast, in both HeLa cells ex-
pressing Pmel17
 
 
 
cs (Fig. 1 D) and LoVo cells expressing
wild-type Pmel17 (Fig. 1 E), only the 
 
 
 
100-kD P1 band
and not M
 
 
 
 was observed, indicating that cleavage did not
occur (a faint residual band that co-migrates with M
 
 
 
 in
LoVo cells expressing Pmel17
 
 
 
cs may result from cleavage
by NARC-1, a related protease that is active within the ER
and for which a sequence similar to the consensus recogni-
tion site is generated by the KR
 
468–469
 
→
 
QQ mutation;
Seidah et al., 2003). M
 
 
 
 was restored in LoVo cells by coex-
pression of both Pmel17 and furin, but not Pmel17
 
 
 
cs and
furin (Fig. 1 E). Thus, furin or a similar PC can cleave
Pmel17 at the dibasic recognition site. Importantly, cleavage
at the only other dibasic sites in Pmel17, KR
 
147
 
, or RR
 
192
 
,
would not generate fragments of the appropriate size for M
 
 
 
and M
 
 
 
.
To determine whether a furin-like PC cleaves Pmel17 in
melanocytic cells, we inhibited PCs in the pigmented hu-
man melanoma, MNT-1, by expressing 
 
 
 
1
 
-antitrypsin Port-
land (
 
 
 
1
 
-PDX), a PC-specific variant of 
 
 
 
1
 
-antitrypsin in-
hibitor (
 
 
 
1
 
-AT; Anderson et al., 1993; Jean et al., 1998,
2000). FLAG epitope–tagged 
 
 
 
1
 
-PDX or 
 
 
 
1
 
-AT were ex-
pressed in MNT-1 cells by infection with recombinant ade-
noviruses. Transgene expression and Pmel17 processing
were assessed by metabolic pulse/chase, immunoprecipita-
tion, SDS-PAGE, and phosphorimaging analysis. Both
transgenes were efficiently expressed, although a lower mul-
 
tiplicity of infection (moi) with the 
 
 
 
1
 
-PDX virus was re-
quired to obtain the same level of expression as 
 
 
 
1
 
-AT (Fig.
2 A; likely due to contaminating nonrecombinants in the
 
 
 
1
 
-AT preparation). As described previously, Pmel17 in un-
infected cells first appears as endoH-sensitive P1 and
Pmel17-s forms (Berson et al., 2001). P1 is the full-length
core glycosylated precursor, and Pmel17-s is the product of
an alternatively spliced mRNA that is generated in melano-
cytic cells (Nichols et al., 2003), but not transfected HeLa
cells (Berson et al., 2001); Pmel17-s is distinguished from
M
 
 
 
 based on its direct reactivity with 
 
 
 
Pep13h, its appear-
ance in the pulse-labeled samples, and its sensitivity to En-
doH (see Fig. 5). P1 and Pmel17-s are subsequently modi-
fied in the Golgi to endoH-resistant P2, and P2 is then
cleaved to M
 
 
 
 and M
 
 
 
 (Fig. 2 B, lanes 1–5). All fragments
disappeared from detergent cell lysates with a half-life of 2.5
h. In cells expressing 
 
 
 
1
 
-AT, the pattern and kinetics of
Pmel17 processing were virtually unchanged (Fig. 2 B, lanes
6–10). However, in cells expressing 
 
 
 
1
 
-PDX, as in HeLa
cells expressing Pmel17
 
 
 
cs, P2 accumulated, and generation
of M
 
 
 
/M
 
 
 
 was inhibited by at least 90% (Fig. 2 B, lanes
11–20; Fig. 2 C). Cleavage was equally inhibited in cells ex-
pressing two different levels of 
 
 
 
1
 
-PDX (Fig. 2, B and C),
likely reflecting the secretion of 
 
 
 
1
 
-PDX by infected cells
and uptake by uninfected cells. By contrast, 
 
 
 
1
 
-PDX did not
affect the maturation and half-life of another melanosome
protein, Tyrp1 (unpublished data). These data confirm that
furin or a furin-like PC mediates Pmel17 cleavage in me-
lanocytic cells.
 
PC cleavage is not required for localization of Pmel17 
to multivesicular endosomes
 
Pmel17 transits through a multivesicular coated endosome
en route to striated stage II premelanosomes in pigmented
cells (Raposo et al., 2001). Similarly, Pmel17 in transfected
HeLa cells localizes mainly to intralumenal vesicles (ILVs) of
MVBs (Berson et al., 2001). To determine whether this lo-
calization step requires PC-dependent cleavage, HeLa cells
expressing wild-type Pmel17 or Pmel17
 
 
 
cs were analyzed by
immunofluorescence microscopy (IFM) and immunoelec-
tron microscopy (IEM). Pmel17
 
 
 
cs, like wild-type Pmel17
(Berson et al., 2001), localized by IFM to vesicles that over-
lapped with a large fraction of vesicles that contained the late
endosome/lysosome marker, LAMP1 (unpublished data).
IEM of ultrathin cryosections identified these structures as
MVBs, in which Pmel17
 
 
 
cs accumulated largely in the ILVs
(Fig. 3 A). Similarly, Pmel17 localization to multivesicular-
coated endosomes in MNT-1 melanoma cells was not af-
fected by expression of 
 
 
 
1
 
-PDX (Fig. 4 E). Together with the
normal half-life in TX cell lysates and kinetics of conversion
from P1 to P2 (Fig. 1 C and Fig. 2 B), these data indicate
that ER export and post-Golgi trafficking of Pmel17 are not
dramatically influenced by loss of PC cleavage.
 
Formation of fibrous striations requires PC cleavage
 
Structures similar to the fibrous striations of premelanosomes
are frequently observed in MVBs of transfected HeLa cells that
express high levels of wild-type Pmel17 (Berson et al., 2001).
By contrast, such structures were not observed in HeLa cellsT
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expressing comparable or higher levels of Pmel17
 
 
 
cs (Table I
and Fig. 3 E). Instead, Pmel17
 
 
 
cs accumulated in irregular
electron-dense aggregates within compartments that contained
intralumenal membrane sheets rather than vesicles, and that
thus resembled lysosomes (Fig. 3, B and E). Accordingly, these
compartments labeled densely for LAMP1 by IEM (unpub-
lished data). These data suggest that if Pmel17 is not cleaved
by PCs, its ability to nucleate striation formation is inhibited
concomitant with enhanced movement from late endosomes
to lysosomes. The dense aggregates observed by IEM may rep-
resent intermediates in the degradation of Pmel17 by lysoso-
mal proteases (see Fig. 4 and Fig. 5).
To determine whether Pmel17 cleavage was required for
striation formation in melanocytic cells, MNT-1 cells ex-
pressing 
 
 
 
1
 
-PDX or 
 
 
 
1
 
-AT were analyzed by EM (Fig. 4).
Because 
 
 
 
1
 
-PDX or 
 
 
 
1
 
-AT are secreted, even uninfected
cells in the cultures were partially subject to their effects. Al-
though expression of  1-AT had little effect on the abun-
dance or morphology of melanosomes or on the localization
of Pmel17 (Fig. 4, A and B), many cells expressing  1-PDX
were depleted of striated stage II premelanosomes, and most
accumulated irregular pigment-containing structures (Fig. 4,
C–E). Some of these structures were multivesicular (Fig. 4
D), and others contained irregular melanin aggregates (Fig.
4 C). Ultrastructurally normal stage II, III, and IV melano-
somes in these cells were reduced in number; quantitative
analyses of 50 cell profiles in Epon sections indicated that
16% lacked any stage II premelanosomes, and an additional
72% had disorganized melanosome structures. By IEM,
Pmel17 in these cells accumulated in membrane-enclosed
structures with disordered aggregates of fuzzy electron-dense
material, similar to those observed in Pmel17 cs-expressing
HeLa cells (compare Fig. 4 A with Fig. 4 E); these likely rep-
resent malformed stage II premelanosomes, late endosomes,
or lysosomes with mistargeted Pmel17. By contrast, Pmel17
labeling in both the limiting and intralumenal membranes
of coated endosomes in MNT-1 cells was not affected by  1-
PDX expression (Fig. 4 E). These results confirm the impor-
tance of Pmel17 cleavage in the formation of characteristic
intralumenal striations of melanosomes.
Association of the lumenal domain fragment 
with TX-insoluble complexes
The dependence of striation formation on PC cleavage of
Pmel17 would support a model in which M  fragments
Figure 2. PCs mediate Pmel17 cleavage 
in melanocytic cells. MNT-1 cells were 
uninfected (U) or infected with recom-
binant adenoviruses encoding tTA (moi 
of 20) and either FLAG-tagged  1-AT 
(moi of 20; A20) or  1-PDX at moi of 20 
(P20) or 5 (P5). Two days after infection, 
cells were metabolically pulse labeled 
and chased for the indicated periods of 
time. Immunoprecipitates from TX cell 
lysates at indicated time points were 
fractionated by SDS-PAGE and analyzed 
by phosphorimaging. (A) Epitope-tagged 
 1-AT and  1-PDX immunoprecipitated 
from pulse-labeled cell lysates using 
an anti-FLAG antibody. Similar levels 
of transgene expression were obtained 
using  1-PDX at moi of 5 and  1-AT 
at moi of 20. (B) Pmel17 immuno-
precipitated using  PEP13h. Only the 
relevant portion of the gels are shown; 
no other specific bands were consistently 
observed. The intensity of the lower 
part of the gel was amplified 2  to 
emphasize the M  band. Positions of 
molecular weight markers (right) and 
of P1, Pmel17-s, P2, M , and M  (left) 
are noted. Pmel17-s is the product of 
an alternatively spliced Pmel17 mRNA. 
(C) Quantitation of the signal intensity 
of P1, P2, and M  from B. Data represent 
the percentage of signal from each band relative to the values for P1 at 0 chase for each group (average from three experiments). Note 
that the predicted cysteine and methionine content of M  represents 42% of that present in full-length Pmel17.
Table I. Quantitation of Pmel17 localization to MVBs and 
striations in transfected HeLa cells
HeLa Pmel17 WT HeLa Pmel17 cs
MVBs 57% 51%
MVBs   striations 43% 2%
a
Lysosomes   aggregates – 47%
HeLa cells expressing Pmel17 WT or Pmel17 cs were fixed, and ultrathin
cryosections were labeled with HMB50 anti-Pmel17 antibody and PAG-10.
50 cell profiles of each were analyzed for the presence of gold labeling in
MVBs or lysosomes, and for the association of the gold particles with
striation-like structures or aggregates. Percentages are relative to the total
number of structures analyzed in all cell profiles (150 compartments for
WT, 160 for  cs).
aThese correspond to MVBs with non-organized proteinaceous material.T
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Figure 3. Cleavage site–deficient Pmel17 localizes to MVBs, but fails to form fibers. Transiently transfected HeLa cells expressing Pmel17 cs 
(A, B, and E) or wild-type Pmel17 (C and D) were analyzed by either IEM (A, B, and D) or standard EM (C and E). (A, B, and D) Ultrathin 
cryosections were immunogold labeled with HMB50 and PAG-10; in D, sections were double labeled with anti-CD63 and PAG-15. (A) A 
typical Pmel17 cs-expressing cell showing predominant labeling on ILVs of multivesicular late endosomes. (B) A cell with very high Pmel17 cs 
expression; note the gold labeling over electron-dense aggregates in compartments with multiple layers of membranes (stars). (D) A cell with 
high wild-type Pmel17 expression; note the gold labeling over ILVs and fibrous structures within MVBs (arrows), and exclusion of CD63 
labeling from the striated regions. (C) Standard EM of a cell expressing wild-type Pmel17. Note the fibers within MVBs (arrows). (E) Standard 
EM of a cell expressing Pmel17 cs. Note the accumulation of electron-dense material in MVBs, but no obvious fibers (arrowheads). Bars, 200 nm.T
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Figure 4. Disruption of melanosome morphology in MNT-1 cells expressing  1-PDX. MNT-1 cells infected with recombinant adenoviruses 
expressing tTA and either  1-AT (A and B) or  1-PDX (C–E) were analyzed by either IEM (A and E) or standard EM (B–D). (A and E) 
Ultrathin cryosections were immunogold labeled with HMB50 and PAG-10. (A and B) Note the characteristic striations of stage II and III 
premelanosomes (II and III) in cells expressing  1-AT. By IEM, these structures are densely labeled for Pmel17. (C and D) Note the absence of 
normal stage II and III premelanosomes in cells expressing  1-PDX, and the appearance of unusual melanin aggregates in disordered arrays 
(C, stars) and multivesicular structures (D, arrows). (E) By IEM, Pmel17 is detected normally in endosomes with a planar clathrin coat 
(bottom left), but dense labeling is limited to abnormal, nonstriated, multivesicular structures with the shape of stage II premelanosomes 
(II). PM, plasma membrane. Bars, 200 nm.T
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form intralumenal proteinaceous fibrils upon their release
from membranes. By analogy to amyloid, such fibrils might
be insoluble in nondenaturing detergents such as TX.
Indeed, M  was observed in TX-insoluble fractions of MNT-1
cells. By Western blotting, an endoH-resistant, N-glyca-
nase F–sensitive M  band was detected in whole MNT-1
cell lysates with  Pmel-N (antibody to the lumenally ex-
posed NH2 terminus of Pmel17), but not with  Pep13h
(antibody to the cytoplasmically exposed COOH terminus;
Fig. 5 A), distinguishing it from the endoH-sensitive,
 Pep13h-reactive alternative splice product, Pmel17-s. Al-
though most M , Pmel17-s, and P1 isoforms were soluble
in TX, a significant fraction of M  was detected in the TX-
insoluble pool (Fig. 5 B).
Formation of TX-insoluble M  was kinetically linked to
both cleavage and dissociation from M  by a metabolic
pulse/chase assay in which TX-insoluble material from cell
lysates was extracted by heating in 8M urea. Pmel17 iso-
Figure 5. M  accumulation in TX-
insoluble fractions of MNT-1 cells and 
inhibition by  1-PDX. (A and B) Western 
blot analyses of MNT-1 cell fractions. 
Lysates fractionated by SDS-PAGE were 
probed with antibodies  Pep13h (to 
COOH terminus) or  Pmel-N (to NH2 
terminus). (A) Whole-cell lysates were 
untreated or treated with endoH (H) or 
N-glycanase F (F). (B) Whole-cell lysates 
(T) and TX-soluble (S) or -insoluble (I) 
material were analyzed directly. Relevant 
bands are indicated; bands annotated 
with   are glycosidase cleavage products. 
(C–F) Pulse-chase/immunoprecipitation 
analyses of M  formation in MNT-1 
cells. Metabolically pulse-labeled and 
chased MNT-1 cells were extracted with 
TX, and TX-insoluble pellets were re-
extracted in lysis buffer containing 8M 
urea at 60 C. TX-soluble and -insoluble/
urea extracted fractions (after dilution 
of the urea) were sequentially immuno-
precipitated first with normal rabbit 
serum, then with  PEP13h, and finally 
with  Pmel-N. Immunoprecipitates 
were fractionated by SDS-PAGE and 
analyzed by phosphorimaging. Chase 
times (h) are indicated at top (C and F) or 
bottom (D and E); migration of molecular 
weight markers and relevant bands are 
indicated to the side. (C)  Pep13h and 
 Pmel-N immunoprecipitates from both 
fractions are shown. Panels on the right 
were exposed 22  longer than those 
on the left because of vastly reduced
efficiency of immunoprecipitation after 
treatment of lysates with urea (unpub-
lished data). Note the appearance of M  
in  Pmel-N immunoprecipitates at later 
time points. (D) The intensity of indicated 
bands in each lane from the soluble 
fraction of C was quantitated by phos-
phorimaging, and ratios of the intensities 
of P1 to P2, Pmel17-s/M  (M /X), and 
M  at each time point, precipitated 
by either  Pep13h or  Pmel-N, were 
calculated and plotted; the Pmel17-s 
and M  bands were summed because 
they could not be easily resolved. Note 
that for each time point, ratios were 
similar for both antibodies. (E) Intensities 
of P1, P2, Pmel17-s, and M  bands were summed at each time point for both antibodies in both soluble (sol) and insoluble (insol) fractions, 
and plotted as a percentage of the value at time 0. Note the loss of material from all fraction/antibody combinations except the insoluble fraction 
precipitated with  Pmel-N, in which intensity increased over time. (F) Cells were uninfected or infected with recombinant adenoviruses 
expressing  1-PDX at moi of 5, PDX(5); or 20, PDX(20); or  1-AT at moi of 20, AT(20), before the experiment; shown are only the relevant 
regions of the  Pmel-N immunoprecipitates from the TX insoluble fraction. Arrows, bands that co-migrate with M  or a novel product (?) 
precipitated only from cells expressing  1-PDX.T
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forms from this TX-insoluble pool (after dilution of the
urea) and from the soluble fraction were sequentially immu-
noprecipitated with  PEP13h and then  Pmel-N, then ana-
lyzed by SDS-PAGE and phosphorimaging. From the solu-
ble pool,  Pmel-N only immunoprecipitated residual P1,
P2, Pmel17-s, M , and M  in similar proportions as in the
initial  Pep13h immunoprecipitates (Fig. 5, C and D; com-
pare lanes 1–4 with lanes 5–8). From the TX-insoluble pool,
although  Pep13h immunoprecipitated only full-length P1
and Pmel17-s (Fig. 5 C, lanes 9–12), subsequent  Pmel-N
immunoprecipitates additionally contained an  80-kD
band (lanes 13–16); its failure to be depleted by  Pep13h
suggests that this band is M . The intensity of this band in-
creased over time from undetectable at the pulse to most in-
tense by 4 h of chase (Fig. 5, C and E). Thus, at least a por-
tion of M  was released from M  during the chase and
accumulated in TX-insoluble complexes.
To confirm the identity of this TX-insoluble band as M 
and to determine whether its accumulation required PC
cleavage, MNT-1 cells expressing  1-PDX were similarly an-
alyzed by pulse/chase and immunoprecipitation. As shown
in Fig. 5 F, expression of  1-PDX (but not  1-AT) inhibited
the formation of TX insoluble M . Appearance of the frag-
ment was both delayed and reduced in efficiency by expres-
sion of  1-PDX. Instead, these cells accumulated a larger
fragment of Pmel17, lacking the COOH terminus and pos-
sibly comprising the entire lumenal domain (Fig. 5 F; band
marked “?”). Appearance of this band correlates with the dis-
ordered aggregates observed by IEM (Fig. 4 E), and likely re-
sults from cleavage within the juxtamembrane region by ly-
sosomal proteases. These data show that formation of intact
fibrils correlates with appearance of TX-insoluble M .
The premelanosome fibrils contain TX-insoluble M 
If the fibrils consist of M  fragments, they should label with
antibodies to the Pmel17 lumenal domain, but not to the cy-
toplasmic domain. IEM analyses confirm this prediction. In
MNT-1 cells,  PEP13h labels the coated endosome precursor
to stage II premelanosomes, including the ILVs within them,
but not the striated stage II premelanosomes themselves (Fig.
6 A; also see supplemental materials in Raposo et al., 2001,
available at http://www.jcb.org/cgi/content/full/152/4/809/
DC1/3). Concordantly, in transfected HeLa cells expressing
high levels of Pmel17,  PEP13h labeling is observed on the
ILVs of MVBs (Fig. 6 B), but not on the striated regions that
form within the same multivesicular structures (Fig. 6 C). By
Figure 6. Failure to detect Pmel17 
COOH terminus in striated regions of 
premelanosomes and MVBs. Ultrathin 
cryosections of (A) MNT-1 or (B and C) 
transiently transfected HeLa cells 
expressing wild-type Pmel17 were double 
immunogold–labeled with HMB50 and 
PAG-10 and with  Pep13h and PAG-15. 
(A) A section of MNT-1 cells showing 
labeling by both antibodies on multi-
vesicular coated endosomes (asterisk 
and inset), but only by HMB50 on stage 
II premelanosomes (II). Note the intra-
lumenal labeling by  Pep13h in the 
marked coated endosome (asterisk). 
(B) A typical section of transfected HeLa 
cells containing abundant multivesicular 
compartments. Note the labeling with 
both antibodies, with HMB50 labeling 
on the lumenal face and  PEP13h labeling 
primarily on the interior of the vesicles. 
(C) A section from a transfected HeLa 
cell demonstrating nascent striations. 
Note the absence of  PEP13h labeling 
in the striated regions (arrows) and on 
closely apposed membranes (arrows). 
Bars, 200 nm.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
Proprotein convertases and melanosome biogenesis | Berson et al. 529
contrast, antibodies to the Pmel17 lumenal domain label both
the ILVs and the striations (Fig. 6, B and C). These data con-
firm that the fibrils lack the cytoplasmic domain present on
full-length Pmel17 and the M  fragment.
To determine directly whether the premelanosome fibrils
contain TX-insoluble M  fragments, MNT-1 cells were an-
alyzed by subcellular fractionation. Light and dense fractions
were harvested from post-nuclear cell homogenates by dif-
ferential centrifugation, and membranes isolated from each
fraction were subfractionated into TX-soluble and -insoluble
pools (Fig. 7 A). The TX-soluble pools of both fractions
contained P1 and Pmel17-s (representing pre-Golgi–local-
ized Pmel17) and M  (Fig. 7 B, lanes 6 and 9); these prod-
ucts were nearly completely excluded from the TX-insoluble
pool (lanes 7 and 10). By contrast, although M  was also
distributed among both membrane fractions, within the
dense membrane fraction it was enriched in the TX-insolu-
ble pool (Fig. 7 B, lane 7). IEM analyses of the dense mem-
brane fraction revealed melanosomes of all stages and other
dense organelles such as lysosomes and late endosomes (Fig.
7, C and D). The limiting membranes of mature melano-
somes labeled densely for Tyrp1 (Fig. 7 C); very little label-
ing for Pmel17 was observed on these nonpermeabilized,
fixed samples (Fig. 7 D), likely due to sequestration within
the lumen at a distance from the limiting membrane. As ex-
pected, no intact structures were recovered from the TX-sol-
uble pool by IEM (unpublished data). By contrast, the insol-
uble pool consisted primarily of masses of pigment and
nonpigmented fibrous structures, largely free of limiting
membranes, that appeared to derive from stage II–IV mela-
nosomes (Fig. 7, E–G). The fibers labeled densely with anti-
body to the Pmel17 lumenal domain (Fig. 7, E and G), but
not with  Pep13h (not depicted) or antibody to Tyrp1 (Fig.
7 F); by contrast, remaining limiting membrane surround-
ing the pigment labeled with antibody to Tyrp1 but not to
Pmel17 (Fig. 7 F). Thus, TX-insoluble fibers contain TX-
insoluble M  fragments. Together, the data show that for-
mation of striations results at least in part from the incor-
poration of M  fragments into nonmembrane associated,
TX-insoluble fibrous structures.
Discussion
Morphogenetic properties of resident intraorganellar pro-
teins must be tightly regulated to ensure that organelle bio-
genesis proceeds at the proper place and time. One way to
regulate these properties is by specific modifications of resi-
dent proteins during passage through transport intermedi-
ates. Our results demonstrate that premelanosome morpho-
genesis is regulated at the level of initiating intraorganellar
fibrillogenesis through controlled PC-dependent proteolysis
of a resident glycoprotein. These observations may reflect a
more general requirement for regulated proteolysis of resi-
dent proteins by PCs and other proteases in the biogenesis of
lysosome-related organelles; a similar model has been in-
voked for the formation of Weibel-Palade bodies in endo-
thelial cells (Journet et al., 1993) and lamellar bodies in lung
epithelial cells (Guttentag et al., 2003). Furthermore, our
results extend the parallels between lysosome-related or-
ganelles and conventional dense core secretory granules, for
which a biogenetic role for PCs is well established (Arvan
and Castle, 1998). Finally, our data elucidate the molecular
basis for a well-known but enigmatic feature of melanosome
morphology, the intralumenal fibrous striations, and show a
striking parallel between the physiologic formation of these
fibrils and the pathogenic formation of amyloid fibers.
Role of PCs in organelle morphogenesis
PC cleavage is required to activate numerous secreted and
cell surface proproteins and viral fusion proteins (Thomas,
2002), but few intracellular substrates are known. Here, we
used two approaches to show that cleavage of Pmel17 by fu-
rin or a related PC is required to generate premelanosome
fibrils. The formation of both fibrils and the mature
Pmel17-derived fragments, M  and M , was blocked by (1)
mutagenesis of the PC recognition site of Pmel17 in an ex-
ogenous expression system, and (2) inhibition of PC activity
in a melanocytic cell line. Previous reports demonstrated de-
fects in Weibel-Palade bodylike structures in an ectopic ex-
pression system upon mutagenesis of a PC site in von Wille-
brand factor (Journet et al., 1993), and in lamellar body
formation in lung epithelial type II cells upon treatment
with a cysteine protease inhibitor (Guttentag et al., 2003).
However, this is the first time that both approaches have
been used to conclusively demonstrate a role for PCs or
other proteases in the activation of a single substrate protein
to initiate morphogenesis of a lysosome-related organelle.
The relevant PC in melanocytic cells may be furin; furin is
expressed in melanocytic cells (unpublished results), is capa-
ble of cleaving Pmel17 in reconstituted LoVo cells (Fig. 1
E), and is somewhat selectively inhibited by  1-PDX (Jean
et al., 1998). On the other hand, the complement of PCs ex-
pressed by pigment cells is not known, and a different PC
may function physiologically because  1-PDX can inhibit
other PCs (Jean et al., 1998), and the Pmel17 cleavage site
differs from the consensus furin recognition site (Fig. 1 B).
We have shown that cleavage occurs within an acidic, post-
Golgi, prelysosomal compartment that kinetically precedes
stage II premelanosomes (Berson et al., 2001), consistent
with the known localization of furin and other PCs to the
TGN, endosomes, and secretory granules (Molloy et al.,
1999; Thomas, 2002). The residual cleavage that occurs in
the presence of brefeldin A and that results in a small pool of
endoH-sensitive M  (Berson et al., 2001), like the residual
cleavage of Pmel17 cs in LoVo cells (Fig. 1 E), is likely
mediated by NARC-1 or a related protease (Seidah et
al., 2003). Of note, the accumulation of Golgi-processed
Pmel17 observed upon inhibition of PC cleavage adds to the
growing evidence that premelanosomes derive from post-
Golgi compartments, and not from smooth ER (Kushimoto
et al., 2001).
In MNT-1 cells expressing  1-PDX, striated structures
were less abundant than in control cells, and many cells dis-
played numerous abnormal pigment-containing structures
(Fig. 4). Because melanogenic enzymes such as tyrosinase and
Tyrp1 are normally delivered to preformed stage II preme-
lanosomes (Raposo et al., 2001), these unusual pigmented
structures likely represent the products of malformed preme-
lanosomes, depleted of fibrils, to which melanogenic enzymes
were still delivered. The failure to completely deplete stage IIT
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premelanosomes in  1-PDX–treated cells was likely due to the
short duration of expression after adenovirus infection; “nor-
mal” melanosomes of all stages present within  1-PDX–
expressing cells likely represent later stage melanosomes that
were in the process of forming, and/or partial fibril formation
by a pool of properly cleaved Pmel17 that was present within
abundant stage I premelanosomes, before a threshold of  1-
PDX expression. Tonic exposure to  1-PDX for extended pe-
riods of time would likely further reduce the level of normal
melanosomal structures in these cells, and may permit a time-
line for melanosome maturation to be derived.
Composition and formation of striations and parallels 
with fibrillary diseases
The striated fibrils of stage II and III melanosomes have been
thought to consist of protein with no underlying membrane
based on their periodicity of electron lucence and density and
the frequent appearance of a “zigzag” shape by EM (Birbeck
et al., 1956; Moyer, 1966; Maul, 1969; Hearing et al., 1973).
This interpretation seemed inconsistent with the ability of
the integral membrane protein, Pmel17, to induce formation
of and become incorporated into the striations (Berson et al.,
2001; Raposo et al., 2001). We now reconcile these observa-
Figure 7. Cofractionation of TX-insoluble M  and premelanosome fibers. (A) Scheme for fractionation of post-nuclear supernatants (PNS) 
from homogenates of MNT-1 cells. Boxed fractions were analyzed by Western blotting in B. (B) Equal cell equivalents from each fraction 
were analyzed by SDS-PAGE and Western blotting with  Pmel-N,  Pep13h, or the anti-tubulin antibody YL 1/2, as indicated. Shown are the 
relevant portions of each gel; positions of molecular weight markers (right) and relevant proteins (left) are indicated. Note the enrichment of 
only M  in the TX-insoluble pool of the DM fraction (lane 7). (C–G) IEM analyses of relevant fractions using HMB45 (to Pmel17 lumenal 
domain) or TA99 (to Tyrp1) and PAG-10. (C and D) Nonsolubilized membranes from the dense fraction (lane 5 in B) labeled with TA99 (C) or 
HMB45 (D). Note the labeling for Tyrp1 on the limiting membrane of highly pigmented structures (particularly in inset), and the absence of 
HMB45 labeling on these nonpermeabilized, whole-mounted fractions. (E–G) TX-insoluble membranes from the dense fraction (lane 7 in B) 
labeled with HMB45 (E and G) or TA99 (F). Note the dense labeling of fibrous structures (arrows), including relatively intact contents of a 
stage II premelanosome (G, inset), by HMB45. TA99 only sparsely labels residual limiting membranes (F, arrows). Bars, 200 nm.T
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tions by showing that the PC cleavage product, M , is even-
tually released from membranes and accumulates in TX-
insoluble complexes. The insolubility of these complexes ex-
plains our previous inability to observe M  released from
M  in the TX-soluble fraction (Berson et al., 2001) and the
short half-life of TX-soluble Pmel17 (Kobayashi et al., 1994;
Donatien and Orlow, 1995; Berson et al., 2001), and sup-
ports earlier evidence for Pmel17-derived fragments in deter-
gent-insoluble fractions of partially purified melanosomes
(Orlow et al., 1993; Zhou et al., 1994). The identity of M 
is confirmed by (1) its immunoreactivity with  Pmel-N but
not  Pep13h and its insensitivity to endoH; (2) the failure to
generate M  and M  upon mutagenesis of KR
469, inhibition
of PCs by  1-PDX, or expression in PC-deficient LoVo cells;
(3) the lack of any other potential dibasic cleavage sites in
Pmel17 that could generate the appropriate sized fragments;
and (4) the co-migration of intracellular M  with secreted
Pmel17 (Berson et al., 2001), for which the sequence is
known to end at V
467 (Maresh et al., 1994). The presence of
TX-insoluble, M -dissociated M  on isolated fibrils and the
dependence of striation formation on PC cleavage of Pmel17
indicates that (1) Pmel17 is not only sufficient, but also nec-
essary for the generation of striations; and (2) the striations
consist of insoluble complexes composed at least in part of
M  without M  and underlying membrane.
How does M  become incorporated into detergent-insolu-
ble complexes? M  must first be released from the integral
membrane M  fragment, to which it is disulfide bonded on
ILVs of multivesicular endosomes (Berson et al., 2001; Ra-
poso and Marks, 2002). By analogy to the “sorting by reten-
tion” model of secretory granule formation (Arvan and Castle,
1998), the MVB may provide a structural framework to se-
quester Pmel17 and other molecules required for striation for-
mation from other endosome components. Release of M 
from the ILV must be mediated by either reduction of the dis-
ulfide bonds or proteolytic digestion of M ; the latter is more
likely, given the oxidative nature of melanin intermediates,
the presence of lysosomal hydrolases in melanosomes (Orlow,
1995), and evidence for proteolytic maturation of Pmel17 in
stage II premelanosome-enriched subcellular fractions (Chia-
menti et al., 1996; Kushimoto et al., 2001). We speculate that
release of M  from M  is accompanied by a conformational
change that favors fibrillogenic activity, perhaps facilitated by
the low pH of forming premelanosomes (Raposo et al., 2001).
Lumenal segments within M  may serve to inhibit fibrillo-
genesis because longer Pmel17 fragments generated upon in-
hibition of PCs fail to properly form fibrils.
This model for physiological fibril formation in preme-
lanosome biogenesis is reminiscent of the pathological process
of fibril formation in a number of amyloid diseases. A specific
requirement for PC cleavage and/or acidification in the for-
mation of fibrils is observed in several pathogenic fibrillo-
genic substrates, including gelsolin in familial amyloidoses of
Finnish type (Chen et al., 2001), BRI-L in familial British
dementia (Kim et al., 1999), and pro-islet amyloid polypep-
tide in type II diabetes (Badman et al., 1996). Proteolytic
maturation, acidification, and/or association with detergent-
insoluble lipid rafts—the lipid contents of which are similar
to the ILVs of MVBs (Mobius et al., 2002; Wubbolts et al.,
2003)—are common features in fibril formation by the amy-
loidogenic peptide in Alzheimer’s disease (Esler and Wolfe,
2001; Ehehalt et al., 2003) and by prions (Taraboulos et al.,
1995; Mayer et al., 1996; Zou and Cashman, 2002). Defin-
ing the fibrillogenic determinant within the Pmel17 lumenal
domain and characterizing its properties will likely provide
insights into the mechanism by which fibril formation is fa-
vored by proteolytic maturation, not only in premelano-
somes, but also in these clinically important substrates.
Implications for biogenesis 
of lysosome-related organelles
PCs are well known to regulate the formation of dense
cores in conventional secretory granules by permitting or-
dered aggregation and dense packing of granule contents
(Arvan and Castle, 1998). Our work, together with the
presumed role of PCs or other proteases in the formation
of Weibel-Palade bodies or lamellar bodies, respectively,
demonstrates that proteolytic activation plays a general role
in lysosome-related organelle biogenesis as well. Other fi-
brillogenic substrates may include Langerin, a C-type lec-
tin that is involved in the formation of Birbeck granules in
Langerhans cells (Valladeau et al., 2000). Future studies
will likely confirm the generality of this biogenetic func-
tion of proteases, and may reveal whether fibrillogenic acti-
vation steps are disrupted by genetic diseases of organelle
biogenesis, such as Hermansky-Pudlak Syndrome (Spritz,
1999; Swank et al., 2000).
Materials and methods
Cell culture and transfections
MNT-1 human melanoma cells and furin-deficient LoVo adenocarcinoma
cells (American Type Culture Collection) were maintained in DME con-
taining 10% AIM-V medium (Life Technologies), 20% FBS, nonessential
amino acids, sodium pyruvate, and antibiotics. HeLa cells were cultured
as described previously (Berson et al., 2001). Cells were transiently trans-
fected using either calcium phosphate precipitation (Marks et al., 1996) or
FuGENE™ 6 (Roche) for HeLa or LipofectAMINE™ (Life Technologies) for
LoVo according to manufacturer’s instructions. Cells were analyzed 2–3 d
after transfection.
Antibodies
mAb specific for Tyrp1 (TA99/Mel-5; Thomson et al., 1985) and affinity-
purified rabbit antibody to the Pmel17 COOH terminus ( PEP13h; Berson
et al., 2001) were described previously. Purchased mAbs were HMB50 and
HMB45 (anti-Pmel17; Lab Vision), M2 (anti-FLAG; Sigma-Aldrich), H4A3
(anti-LAMP1; Developmental Studies Hybridoma Bank, Iowa City, IA), anti-
CD63 (Immunotech), and YL 1/2 (anti-tubulin; Accurate Chemical). Rabbit
antiserum  Pmel-N was generated by Genemed Synthesis, Inc. to a syn-
thetic peptide (CTKVPRNQDWLGVSRQLR-CO2H) corresponding to the
human Pmel17 NH2 terminus (residues 24–40), and affinity purified on pep-
tide coupled to SulfoLink beads (Pierce Chemical Co.).  Pmel-N had no re-
activity with untransfected HeLa cells. Protein A gold conjugates were pur-
chased from Dr. J. Slot (Utrecht Medical School, Utrecht, Netherlands).
Plasmids
pCI-Pmel17 encoding the Pmel17 long form in pCI (Promega) has been de-
scribed previously (Berson et al., 2001). Pmel17 cs was generated by site-
directed mutagenesis using two-step amplification (Higuchi et al., 1988),
replacing the endogenous sequence using unique KasI and NsiI sites, and
sequence verified by automated dideoxy sequencing. HA11 epitope-
tagged furin in pSX (Bosshart et al., 1994) was a gift of Dr. J.S. Bonifacino
(National Institutes of Health, Bethesda, MD).
Recombinant virus production and infection
Recombinant adenoviruses encoding the tetracycline-responsive transacti-
vator (tTA) and tetracycline-responsive, FLAG-epitope tagged  1-PDX and
 1-AT were gifts of Drs. G. Thomas and L. Thomas (Vollum Institute, Ore-T
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gon Health Sciences University, Portland, OR; Jean et al., 2000). Viruses
were amplified and titred using the Tissue Culture Infectious Dose 50
method according to the AdEasy™ vector system application manual
(Qbiogene). Crude virus preparations in PBS were used directly for double
infections of MNT-1 cells, according to the AdEasy™ manual, using tTA vi-
rus at moi of 20 and  1-PDX or  1-AT virus at moi of 5 or 20. Infections
were not cytotoxic for MNT-1 cells as judged by trypan blue exclusion,
and resulted in transgene expression in  50% of the cells by IFM. Cells
were harvested 2 d after infection for analyses.
Metabolic labeling and immunoprecipitation
Cells were metabolically pulse labeled for 15–30 min with [
35S]methio-
nine/cysteine and chased for indicated times as described previously (Marks
et al., 1996). Fresh or frozen cell pellets were lysed in 1% (wt/vol) TX for
30 min as described previously (Berson et al., 2000), and lysates were clar-
ified by centrifugation for 15 min at 20,000 g. Where noted, the resulting
TX-insoluble pellets were resuspended in 50  l TX lysis buffer containing
8M urea and heated at 60 C for 10 min. After cooling, samples were di-
luted 20  with TX lysis buffer for immunoprecipitation. Immunoprecipita-
tions, SDS-PAGE on 10% polyacrylamide gels, and phosphorimaging anal-
ysis were performed as described previously (Berson et al., 2000). For
sequential immunoprecipitations, unbound material from the first precipi-
tation was clarified by centrifugation at 20,000 g for 5 min before incuba-
tion with the subsequent immobilized antibody.
Immunoblotting
Western blotting using whole-cell lysates prepared with 1% SDS, and en-
doH/ N-glycanase F treatments were as described previously (Berson et al.,
2000). For fractionation into TX-soluble and -insoluble fractions, 10
6 cells
were resuspended in 200  l lysis buffer containing 1% TX and protease in-
hibitors at 4 C for 2 h. After centrifugation at 20,000 g for 15 min, superna-
tants (TX soluble) were harvested and 6  SDS-PAGE sample buffer was
added before analysis. Pellets (TX insoluble) were washed once with 1% TX
lysis buffer and then resuspended in 1  SDS-PAGE sample buffer for analy-
sis. 8% PAGE/5% methanol transfer buffer was used for  Pmel-N and anti-
tubulin blots, and 12% PAGE/15% methanol transfer buffer for  Pep13h
blots. Immobilon-P membranes (Millipore) with transferred proteins were
probed with indicated antibodies, and bands were detected with alkaline
phosphatase–conjugated goat anti–rabbit Ig, enhanced chemifluorescence,
and phosphorimaging analysis using a fluorescence imaging system (Storm
®
860; Molecular Dynamics, Inc.) and ImageQUANT software (Amersham
Biosciences).
Subcellular fractionation
See Fig. 7 A for schematic. MNT-1 cells ( 10
8) were homogenized with a
hand-held Dounce homogenizer in 4 volumes of buffer I (25 mM Hepes, 1
mM EDTA, 0.1 mM EGTA, and 0.02% sodium azide, pH 7.4) containing
0.25 M sucrose and a cocktail of protease inhibitors (Berson et al., 2000).
Cell debris and nuclei were pelleted at 700 g for 10 min. Post-nuclear su-
pernatants were layered over a cushion of 2.0 M sucrose in buffer I and
centrifuged at 11,000 g for 10 min. The black interface at the cushion
(dense membrane fraction) and the diffuse supernatant (light membrane
fraction) were harvested, and each was subjected to 100,000 g for 60 min
to recover a pellet (total membrane fraction). Pellets were resuspended in
600  l 150 mM NaCl/0.1 M Tris-HCl, pH 8.0; after a sample was removed
for EM analysis, TX was added to a final concentration of 1%, and samples
were rotated at 4 C for 2 h. Samples were then spun at 20,000 g for 15
min, and supernatants (TX-soluble fraction) and pellets (TX insoluble frac-
tion) were harvested. Approximately 3% of the material in each fraction
was used for each lane for Western blotting analyses. An aliquot of each
fraction was fixed for EM analysis as described below.
Electron microscopy
Conventional EM of MNT-1 or transfected HeLa cells was performed as
described previously (Raposo et al., 2001). For IEM, cells were fixed with
2% PFA/0.2% glutaraldehyde and single- or double-immunogold labeling
of ultrathin cryosections was performed as described previously (Raposo et
al., 1997, 2001) using protein A conjugated to 10-nm or 15-nm gold parti-
cles (PAG-10 or -15). For transfected HeLa cells, only cells expressing
comparable levels of wild-type Pmel17 and Pmel17 cs were analyzed in
parallel. Expression per cell was assessed as total expression level (judged
by Western blotting) divided by percentage of transfected cells (judged by
IFM). Relative quantitation as described in the text was performed directly
under the electron microscope by counting the number of affected and un-
affected relevant compartments among 50 cell profiles. For EM analysis of
subcellular fractions, 20- l drops of each fraction, previously fixed with
2% PFA in PHEM buffer, as described in Raposo et al. (2001), were placed
on formvar-carbon–coated EM grids for 30 min. The grids were then im-
munogold labeled, contrasted, and embedded in a mixture of uranyl ace-
tate and methylcellulose as described for ultrathin cryosections (Raposo et
al., 1997).
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